As late phase clinical studies can become complex, we bring innovation and expertise to minimize delays and mitigate risks in your program.
Late phase clinical trials must establish the effectiveness, safety, and cost-effectiveness of a product on a larger scale. To help you provide the evidence and quality data for your drug's market approval submission, we offer:
- An integrated scientific team with decades of experience
- Quality clinical data to drive drug product optimization
- One vendor for streamlined outsourcing and a more cost-effective route to market
Drug product capabilities to accelerate your later phase clinical trials and get your product commercially-ready.
Our facilities in Philadelphia, PA have specialized capabilities for late stage drug product manufacturing that allow for seamless scale up of clinical and commercial drug product batches.
